Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
31.45 HKD | -0.79% | -11.28% | -35.95% |
May. 23 | Keymed's Anti-Rhinosinusitis Drug Set For Priority Review in China | MT |
Apr. 30 | Keymed Biosciences' Allergy Treatment NDA Accepted by NMPA | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.18B | - | |||||
115B | ||||||
105B | ||||||
22.71B | - | |||||
21.83B | - | |||||
18.18B |